Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Primary progressive multiple sclerosis in Iran: A consensus recommendation for diagnosis and management.
Sahraian MA, Baghbanian SM, Langroodi HG, Abolfazli R, Alaie S, Asgari N, Ashtari F, Ayromlouh H, Moghadam NB, Foroughipour M, Majdinasab N, Mohammadianinejad SE, Nickseresht A, Nourian A, Shahmohammadi S, Shayegannejad V, Torabi HR. Sahraian MA, et al. Among authors: langroodi hg. Mult Scler Relat Disord. 2018 Nov;26:112-120. doi: 10.1016/j.msard.2018.09.013. Epub 2018 Sep 12. Mult Scler Relat Disord. 2018. PMID: 30245383 Review. No abstract available.
Neuromyelitis optica and pregnancy.
Zare-Shahabadi A, Langroodi HG, Azimi AR, Sahraian MA, Harirchian MH, Baghbanian SM. Zare-Shahabadi A, et al. Among authors: langroodi hg. Acta Neurol Belg. 2016 Dec;116(4):431-438. doi: 10.1007/s13760-016-0654-x. Epub 2016 Jun 15. Acta Neurol Belg. 2016. PMID: 27306993 Review.
Diagnosis and management of Neuromyelitis Optica Spectrum Disorder (NMOSD) in Iran: A consensus guideline and recommendations.
Sahraian MA, Moghadasi AN, Azimi AR, Asgari N, H Akhoundi F, Abolfazli R, Alaie S, Ashtari F, Ayromlou H, Baghbanian SM, Moghadam NB, Fatehi F, Foroughipour M, Langroodi HG, Majdinasab N, Nickseresht A, Nourian A, Shaygannejad V, Torabi HR. Sahraian MA, et al. Among authors: langroodi hg. Mult Scler Relat Disord. 2017 Nov;18:144-151. doi: 10.1016/j.msard.2017.09.015. Epub 2017 Sep 25. Mult Scler Relat Disord. 2017. PMID: 29141797 Review.
Comparing infusion-related reactions of the first full dose (600 mg) biosimilar ocrelizumab administration with the standard divided protocol in multiple sclerosis patients: a randomized controlled trial study.
Abbasi Kasbi N, Ghadiri F, Sahraian MA, Nahayati MA, Moghadasi AN, Langroodi HG, Poursadeghfard M, Hosseini S, Heidari H, Baghbanian SM, Kamali H, Ameli Z, Shahmohammadi S, Navardi S. Abbasi Kasbi N, et al. Among authors: langroodi hg. Acta Neurol Belg. 2024 Feb;124(1):205-212. doi: 10.1007/s13760-023-02366-z. Epub 2023 Sep 15. Acta Neurol Belg. 2024. PMID: 37715074 Clinical Trial.